SOPHIA ANTIPOLIS, France—Nicox SA (Euronext Paris: FR0013018124, COX), an international ophthalmology company, has announced that two internationally recognized experts in glaucoma, Robert N. Weinreb, MD, distinguished professor and chair, ophthalmology and director, Shiley Eye Institute, University of California San Diego, and Sanjay G. Asrani, MD, professor of ophthalmology, Duke University, will be joining the Nicox Glaucoma Clinical Advisory Board. The advisory board is composed of key clinical investigators and opinion leaders in the field who support and guide the development of our innovative nitric oxide (NO)-donating compounds as potential intraocular pressure (IOP)-lowering medications.
Dr. José Boyer, interim head of R&D at Nicox said, “We are pleased to welcome two highly respected new members to the Nicox Glaucoma Clinical Advisory Board as we advance toward the pivotal Phase 3 results from the first NCX 470 clinical trial in glaucoma and continue to build out our research platform of innovative nitric oxide-donating medications. Both Dr. Weinreb and Dr. Asrani bring vast clinical and research expertise in glaucoma, which will complement and strengthen the existing board composition. We look forward to working closely with them.”

Dr. Weinreb is the director of both the Shiley Eye Institute and the Hamilton Glaucoma Center, holder of the Morris Gleich, MD chair in glaucoma, and is a professor of bioengineering. He received his medical degree from Harvard Medical School. Patients from throughout the world seek his medical and surgical care. Dr. Weinreb is the recipient of numerous prestigious awards and prizes, and his research has been cited more than 70,000 times.
He is a past president of the Association for Research in Vision and Ophthalmology (ARVO), American Glaucoma Society (AGS), World Glaucoma Association (WGA), American Glaucoma Society Foundation (AGSF), and the Latin Glaucoma Society (PAGS).

Dr. Asrani is professor of ophthalmology at Duke University in Durham, North Carolina, U.S., and director of the Duke Eye Center of Cary and the Duke Glaucoma OCT Reading Center. Dr. Asrani is the recipient of numerous awards, including the Career Development Award from Research to Prevent Blindness, the Helen Keller Scientist Award from the American Glaucoma Society, the Senior Achievement and the Secretariat Awards from the American Academy of Ophthalmology.

Dr. Asrani has over 90 peer reviewed publications and serves on the editorial board of Journal of Glaucoma, Advances in Therapy, and Ophthalmology and Therapeutics. He has developed a new glaucoma implant and a new software for OCT for glaucoma diagnosis.

The other members of the Nicox Glaucoma Clinical Advisory Board are Robert D. Fechtner, MD (Chairman), Donald L. Budenz, MD MPH, Steven Mansberger, MD MPH and Tom R. Walters, MD.